Coming Soon — Website Updates in Progress

By Global Regulatory Submissions Inc.

Why Ocular Safety Matters

Products used near the eye—or products that may contact the eye accidentally—require careful assessment of irritation and serious-eye-damage potential. The relevant question depends on the …

By Global Regulatory Submissions Inc.

What Is a Toxicological Risk Assessment?

A Toxicological Risk Assessment (TRA) evaluates whether exposure to ingredients, impurities, contaminants, or packaging-related substances is acceptable for the intended use. …

By Global Regulatory Submissions Inc.

Classification Before Notification

Whether a product is a cosmetic depends on its composition, intended use, presentation, and claims. Acne treatment, sunscreen, therapeutic, disinfectant, structure/function, or …

By Global Regulatory Submissions Inc.

Begin With the Device and Its Claims

Medical-device regulation starts with the product’s intended purpose, indications, users, operating principle, contact with the body, duration of use, software functions, and risk. …

By Global Regulatory Submissions Inc.

What eCTD Changed

The electronic Common Technical Document (eCTD) is an internationally harmonized format for exchanging regulatory information about medicines. It organizes content, metadata, and lifecycle operations …

By Global Regulatory Submissions Inc.

What a Certificate of Origin Does

A Certificate of Origin identifies the country in which goods originate under the applicable origin rules. Customs authorities, customers, banks, or tendering bodies may request it to …

By Global Regulatory Submissions Inc.

More Than a Commercial Invoice

International shipments often depend on several documents working together. Common records include the commercial invoice, packing list, transport document, customs declaration, …

By Global Regulatory Submissions Inc.

What Is a Certificate of Free Sale?

A Certificate of Free Sale (CFS) is an export document used to confirm that identified products are lawfully marketed, freely sold, or eligible for sale in the exporting …

By Global Regulatory Submissions Inc.

Turning Regulatory Complexity into a Clear Path to Market

Bringing a cosmetic product, pharmaceutical, or medical device to market involves more than developing an innovative product. Businesses must also understand …

Published April 10, 2026

Third-party laboratory testing serves as a cornerstone in regulatory compliance for pharmaceutical, cosmetic, and health product companies. This independent testing provides objective verification of product safety, quality, …

Published April 08, 2026

Timely regulatory submissions are critical for cosmetic and drug products aiming to enter North American markets efficiently. Delays in these processes not only postpone market entry but also escalate operational costs and …

Published April 04, 2026

Navigating the pharmaceutical regulatory environments in Canada and the United States demands a precise understanding of two distinct yet interconnected frameworks. Health Canada and the U.S. Food and Drug Administration …

Published April 01, 2026

In the regulatory consulting landscape, unpredictable and often opaque fee structures present significant challenges for small and medium-sized enterprises, startups, and emerging pharmaceutical and cosmetic firms. These …